Piscataway, NJ, United States of America

James R Pribish

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James R Pribish. Retrieved from https://idiyas.com/inventor/james-r-pribish-jlta8gei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by James R Pribish

Introduction

James R Pribish is an accomplished inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health disorders. His work is characterized by a focus on innovative solutions for treating allergic and inflammatory conditions.

Latest Patents

One of his notable patents is for Pyrimidine hydrazide compounds as PGDS inhibitors. This invention is directed to a compound of formula (I), wherein R, R, R, and L are defined within the patent. The pharmaceutical composition comprising this compound is intended for use in treating allergic and inflammatory disorders, including allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD). This patent highlights his commitment to advancing medical treatments through innovative chemical compounds.

Career Highlights

James R Pribish is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to leverage his expertise in pharmaceutical innovation to develop new therapies that can improve patient outcomes. His work has been instrumental in pushing the boundaries of what is possible in the treatment of complex health issues.

Collaborations

Some of his notable coworkers include Suzanne C Aldous and Michael W Fennie. Their collaborative efforts contribute to the innovative environment at Sanofi, fostering advancements in pharmaceutical research and development.

Conclusion

James R Pribish exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of PGDS inhibitors, demonstrate the potential of targeted therapies in treating significant health challenges. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…